Table of Content
?TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hyperimmune Globulins
1.2 Key Market Segments
1.2.1 Hyperimmune Globulins Segment by Type
1.2.2 Hyperimmune Globulins Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hyperimmune Globulins Market Overview
2.1 Global Market Overview
2.1.1 Global Hyperimmune Globulins Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Hyperimmune Globulins Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hyperimmune Globulins Market Competitive Landscape
3.1 Global Hyperimmune Globulins Sales by Manufacturers (2017-2022)
3.2 Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2017-2022)
3.3 Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hyperimmune Globulins Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Hyperimmune Globulins Sales Sites, Area Served, Product Type
3.6 Hyperimmune Globulins Market Competitive Situation and Trends
3.6.1 Hyperimmune Globulins Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hyperimmune Globulins Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hyperimmune Globulins Industry Chain Analysis
4.1 Hyperimmune Globulins Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hyperimmune Globulins Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hyperimmune Globulins Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hyperimmune Globulins Sales Market Share by Type (2017-2022)
6.3 Global Hyperimmune Globulins Market Size Market Share by Type (2017-2022)
6.4 Global Hyperimmune Globulins Price by Type (2017-2022)
7 Hyperimmune Globulins Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hyperimmune Globulins Market Sales by Application (2017-2022)
7.3 Global Hyperimmune Globulins Market Size (M USD) by Application (2017-2022)
7.4 Global Hyperimmune Globulins Sales Growth Rate by Application (2017-2022)
8 Hyperimmune Globulins Market Segmentation by Region
8.1 Global Hyperimmune Globulins Sales by Region
8.1.1 Global Hyperimmune Globulins Sales by Region
8.1.2 Global Hyperimmune Globulins Sales Market Share by Region
8.2 North America
8.2.1 North America Hyperimmune Globulins Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hyperimmune Globulins Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hyperimmune Globulins Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hyperimmune Globulins Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hyperimmune Globulins Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 CSL Behring
9.1.1 CSL Behring Hyperimmune Globulins Basic Information
9.1.2 CSL Behring Hyperimmune Globulins Product Overview
9.1.3 CSL Behring Hyperimmune Globulins Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Hyperimmune Globulins SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Hyperimmune Globulins Basic Information
9.2.2 Grifols Hyperimmune Globulins Product Overview
9.2.3 Grifols Hyperimmune Globulins Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Hyperimmune Globulins SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Hyperimmune Globulins Basic Information
9.3.2 Biotest Hyperimmune Globulins Product Overview
9.3.3 Biotest Hyperimmune Globulins Product Market Performance
9.3.4 Biotest Business Overview
9.3.5 Biotest Hyperimmune Globulins SWOT Analysis
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Hyperimmune Globulins Basic Information
9.4.2 Kedrion Hyperimmune Globulins Product Overview
9.4.3 Kedrion Hyperimmune Globulins Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Hyperimmune Globulins SWOT Analysis
9.4.6 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Hyperimmune Globulins Basic Information
9.5.2 CBPO Hyperimmune Globulins Product Overview
9.5.3 CBPO Hyperimmune Globulins Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Hyperimmune Globulins SWOT Analysis
9.5.6 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Hyperimmune Globulins Basic Information
9.6.2 Emergent (Cangene) Hyperimmune Globulins Product Overview
9.6.3 Emergent (Cangene) Hyperimmune Globulins Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Hyperimmune Globulins Basic Information
9.7.2 Kamada Hyperimmune Globulins Product Overview
9.7.3 Kamada Hyperimmune Globulins Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Hyperimmune Globulins Basic Information
9.8.2 CNBG Hyperimmune Globulins Product Overview
9.8.3 CNBG Hyperimmune Globulins Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Hyperimmune Globulins Basic Information
9.9.2 Hualan Bio Hyperimmune Globulins Product Overview
9.9.3 Hualan Bio Hyperimmune Globulins Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Hyperimmune Globulins Basic Information
9.10.2 Shanghai RAAS Hyperimmune Globulins Product Overview
9.10.3 Shanghai RAAS Hyperimmune Globulins Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Hyperimmune Globulins Basic Information
9.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Overview
9.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Hyperimmune Globulins Basic Information
9.12.2 ADMA Biologics Hyperimmune Globulins Product Overview
9.12.3 ADMA Biologics Hyperimmune Globulins Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 Hyperimmune Globulins Market Forecast by Region
10.1 Global Hyperimmune Globulins Market Size Forecast
10.2 Global Hyperimmune Globulins Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hyperimmune Globulins Market Size Forecast by Country
10.2.3 Asia Pacific Hyperimmune Globulins Market Size Forecast by Region
10.2.4 South America Hyperimmune Globulins Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hyperimmune Globulins by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Hyperimmune Globulins Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Hyperimmune Globulins by Type (2022-2028)
11.1.2 Global Hyperimmune Globulins Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Hyperimmune Globulins by Type (2022-2028)
11.2 Global Hyperimmune Globulins Market Forecast by Application (2022-2028)
11.2.1 Global Hyperimmune Globulins Sales (K Units) Forecast by Application
11.2.2 Global Hyperimmune Globulins Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
List of Figures
?LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hyperimmune Globulins Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Hyperimmune Globulins Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Hyperimmune Globulins Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hyperimmune Globulins Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Hyperimmune Globulins Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2021)
Table 10. Global Market Hyperimmune Globulins Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Hyperimmune Globulins Sales Sites and Area Served
Table 12. Manufacturers Hyperimmune Globulins Product Type
Table 13. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hyperimmune Globulins
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hyperimmune Globulins Market Challenges
Table 22. Market Restraints
Table 23. Global Hyperimmune Globulins Sales by Type (K Units)
Table 24. Global Hyperimmune Globulins Market Size by Type (M USD)
Table 25. Global Hyperimmune Globulins Sales (K Units) by Type (2017-2022)
Table 26. Global Hyperimmune Globulins Sales Market Share by Type (2017-2022)
Table 27. Global Hyperimmune Globulins Market Size (M USD) by Type (2017-2022)
Table 28. Global Hyperimmune Globulins Market Size Share by Type (2017-2022)
Table 29. Global Hyperimmune Globulins Price (USD/Unit) by Type (2017-2022)
Table 30. Global Hyperimmune Globulins Sales (K Units) by Application
Table 31. Global Hyperimmune Globulins Market Size by Application
Table 32. Global Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
Table 33. Global Hyperimmune Globulins Sales Market Share by Application (2017-2022)
Table 34. Global Hyperimmune Globulins Sales by Application (2017-2022) & (M USD)
Table 35. Global Hyperimmune Globulins Market Share by Application (2017-2022)
Table 36. Global Hyperimmune Globulins Sales Growth Rate by Application (2017-2022)
Table 37. Global Hyperimmune Globulins Sales by Region (2017-2022) & (K Units)
Table 38. Global Hyperimmune Globulins Sales Market Share by Region (2017-2022)
Table 39. North America Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
Table 40. Europe Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Hyperimmune Globulins Sales by Region (2017-2022) & (K Units)
Table 42. South America Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Hyperimmune Globulins Sales by Region (2017-2022) & (K Units)
Table 44. CSL Behring Hyperimmune Globulins Basic Information
Table 45. CSL Behring Hyperimmune Globulins Product Overview
Table 46. CSL Behring Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. CSL Behring Business Overview
Table 48. CSL Behring Hyperimmune Globulins SWOT Analysis
Table 49. CSL Behring Recent Developments
Table 50. Grifols Hyperimmune Globulins Basic Information
Table 51. Grifols Hyperimmune Globulins Product Overview
Table 52. Grifols Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Grifols Business Overview
Table 54. Grifols Hyperimmune Globulins SWOT Analysis
Table 55. Grifols Recent Developments
Table 56. Biotest Hyperimmune Globulins Basic Information
Table 57. Biotest Hyperimmune Globulins Product Overview
Table 58. Biotest Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Biotest Business Overview
Table 60. Biotest Hyperimmune Globulins SWOT Analysis
Table 61. Biotest Recent Developments
Table 62. Kedrion Hyperimmune Globulins Basic Information
Table 63. Kedrion Hyperimmune Globulins Product Overview
Table 64. Kedrion Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Kedrion Business Overview
Table 66. Kedrion Hyperimmune Globulins SWOT Analysis
Table 67. Kedrion Recent Developments
Table 68. CBPO Hyperimmune Globulins Basic Information
Table 69. CBPO Hyperimmune Globulins Product Overview
Table 70. CBPO Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. CBPO Business Overview
Table 72. CBPO Hyperimmune Globulins SWOT Analysis
Table 73. CBPO Recent Developments
Table 74. Emergent (Cangene) Hyperimmune Globulins Basic Information
Table 75. Emergent (Cangene) Hyperimmune Globulins Product Overview
Table 76. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Emergent (Cangene) Business Overview
Table 78. Emergent (Cangene) Recent Developments
Table 79. Kamada Hyperimmune Globulins Basic Information
Table 80. Kamada Hyperimmune Globulins Product Overview
Table 81. Kamada Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Kamada Business Overview
Table 83. Kamada Recent Developments
Table 84. CNBG Hyperimmune Globulins Basic Information
Table 85. CNBG Hyperimmune Globulins Product Overview
Table 86. CNBG Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. CNBG Business Overview
Table 88. CNBG Recent Developments
Table 89. Hualan Bio Hyperimmune Globulins Basic Information
Table 90. Hualan Bio Hyperimmune Globulins Product Overview
Table 91. Hualan Bio Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Hualan Bio Business Overview
Table 93. Hualan Bio Recent Developments
Table 94. Shanghai RAAS Hyperimmune Globulins Basic Information
Table 95. Shanghai RAAS Hyperimmune Globulins Product Overview
Table 96. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Shanghai RAAS Business Overview
Table 98. Shanghai RAAS Recent Developments
Table 99. Sichuan Yuanda Shuyang Hyperimmune Globulins Basic Information
Table 100. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Overview
Table 101. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Sichuan Yuanda Shuyang Business Overview
Table 103. Sichuan Yuanda Shuyang Recent Developments
Table 104. ADMA Biologics Hyperimmune Globulins Basic Information
Table 105. ADMA Biologics Hyperimmune Globulins Product Overview
Table 106. ADMA Biologics Hyperimmune Globulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. ADMA Biologics Business Overview
Table 108. ADMA Biologics Recent Developments
Table 109. Global Hyperimmune Globulins Sales Forecast by Region (K Units)
Table 110. Global Hyperimmune Globulins Market Size Forecast by Region (M USD)
Table 111. North America Hyperimmune Globulins Sales Forecast by Country (2022-2028) & (K Units)
Table 112. North America Hyperimmune Globulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 113. Europe Hyperimmune Globulins Sales Forecast by Country (2022-2028) & (K Units)
Table 114. Europe Hyperimmune Globulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 115. Asia Pacific Hyperimmune Globulins Sales Forecast by Region (2022-2028) & (K Units)
Table 116. Asia Pacific Hyperimmune Globulins Market Size Forecast by Region (2022-2028) & (M USD)
Table 117. South America Hyperimmune Globulins Sales Forecast by Country (2022-2028) & (K Units)
Table 118. South America Hyperimmune Globulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 119. Middle East and Africa Hyperimmune Globulins Consumption Forecast by Country (2022-2028) & (Units)
Table 120. Middle East and Africa Hyperimmune Globulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 121. Global Hyperimmune Globulins Sales Forecast by Type (2022-2028) & (K Units)
Table 122. Global Hyperimmune Globulins Market Size Forecast by Type (2022-2028) & (M USD)
Table 123. Global Hyperimmune Globulins Price Forecast by Type (2022-2028) & (USD/Unit)
Table 124. Global Hyperimmune Globulins Sales (K Units) Forecast by Application (2022-2028)
Table 125. Global Hyperimmune Globulins Market Size Forecast by Application (2022-2028) & (M USD)
List of Figures
Figure 1. Product Picture of Hyperimmune Globulins
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hyperimmune Globulins Market Size (M USD), 2017-2028
Figure 5. Global Hyperimmune Globulins Market Size (M USD) (2017-2028)
Figure 6. Global Hyperimmune Globulins Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hyperimmune Globulins Market Size (M USD) by Country (M USD)
Figure 11. Hyperimmune Globulins Sales Share by Manufacturers in 2020
Figure 12. Global Hyperimmune Globulins Revenue Share by Manufacturers in 2020
Figure 13. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Hyperimmune Globulins Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hyperimmune Globulins Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hyperimmune Globulins Market Share by Type
Figure 18. Sales Market Share of Hyperimmune Globulins by Type (2017-2022)
Figure 19. Sales Market Share of Hyperimmune Globulins by Type in 2021
Figure 20. Market Size Share of Hyperimmune Globulins by Type (2017-2022)
Figure 21. Market Size Market Share of Hyperimmune Globulins by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hyperimmune Globulins Market Share by Application
Figure 24. Global Hyperimmune Globulins Sales Market Share by Application (2017-2022)
Figure 25. Global Hyperimmune Globulins Sales Market Share by Application in 2021
Figure 26. Global Hyperimmune Globulins Market Share by Application (2017-2022)
Figure 27. Global Hyperimmune Globulins Market Share by Application in 2020
Figure 28. Global Hyperimmune Globulins Sales Growth Rate by Application (2017-2022)
Figure 29. Global Hyperimmune Globulins Sales Market Share by Region (2017-2022)
Figure 30. North America Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Hyperimmune Globulins Sales Market Share by Country in 2020
Figure 32. U.S. Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Hyperimmune Globulins Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Hyperimmune Globulins Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Hyperimmune Globulins Sales Market Share by Country in 2020
Figure 37. Germany Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Hyperimmune Globulins Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hyperimmune Globulins Sales Market Share by Region in 2020
Figure 44. China Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Hyperimmune Globulins Sales and Growth Rate (K Units)
Figure 50. South America Hyperimmune Globulins Sales Market Share by Country in 2020
Figure 51. Brazil Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hyperimmune Globulins Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Hyperimmune Globulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Hyperimmune Globulins Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Hyperimmune Globulins Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Hyperimmune Globulins Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Hyperimmune Globulins Market Share Forecast by Type (2022-2028)
Figure 65. Global Hyperimmune Globulins Sales Forecast by Application (2022-2028)
Figure 66. Global Hyperimmune Globulins Market Share Forecast by Application (2022-2028)